INFORMATION BY CANCER TYPE

Myeloma

Feature Video
Multiple Myeloma Defined
Dr Noopur Raje opens this program with a brief discussion on the basics of multiple myeloma. She describes what the disease is, highlights key risk factors, and explains how she helps educate her patients on their diagnosis. Cynthia Harrington discusses her role as a nurse practitioner when working with multiple myeloma patients and why a team-based approach between healthcare providers and the patient is important.
FDA Approves Darzalex Combination for Myeloma Treatment
BY Jason M. Broderick
The Food and Drug Administration (FDA) granted an approval to Darzalex (daratumumab) for use in combination with Pomalyst (pomalidomide) and dexamethasone for patients who have multiple myeloma who have two or more prior therapies, including a proteasome inhibitor and Revlimid (lenalidomide).
Myeloma Immunotherapy Trials Paused
BY Jason Harris
Merck will be pausing two trials testing Keytruda in patients with multiple myeloma.
Therapy Shows High Remission Rates in Multiple Myeloma
BY Jason Harris
Many patients with relapsed or refractory multiple myeloma saw clinical remission with CAR T-cell therapy.
Advocacy Group Demonstrates that Educating Patients Improves Their Treatment Decisions
BY Kathy Giusti, M.B.A.
Why do some patients succumb to their cancer in a matter of months, while others with the same disease live for years or even decades? 
 
Moving Mountains for Multiple Myeloma Kilimanjaro 2017
‚ÄčA team of patients, researchers, advocates and loved ones climbed Mount Kilimanjaro, Africa's highest mountain, to raise money for multiple myeloma awareness and research, benefitting the Multiple Myeloma Research Foundation.
200 Miles - One Patient's Journey for MMRF
BY Tribeca Film Festival
Multiple myeloma advocate Eric Gelber makes history. Watch him as he makes his 200-mile journey.
Moving Mountains for Multiple Myeloma: The Peak Is Just the Beginning
BY Katie Kosko
Patients with multiple myeloma climbed Mount Kilimanjaro to raise money for a cure.
Looking Ahead: What's New In CAR T-Cell Therapy for Hematologic Malignancies
BY Rebecca Bernaski
Jim Kochenderfer, M.D., lends insight to the future of CAR T-cell therapy for hematologic malignancies.
Make Multiple Myeloma Clinical Trials More Diverse
BY Lauren M. Green
It is vital to have diverse groups of patients register for clinical trials so that treatment advances can continue to be made.
Kyprolis Duo Improves Survival in Multiple Myeloma
BY Jason M. Broderick
Kyprolis (carfilzomib) plus dexamethasone improved overall survival for patients with relapsed or refractory multiple myeloma. 
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Myeloma CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
Expert-reviewed information summary about the treatment of plasma cell neoplasms (including multiple myeloma).
Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
Expert-reviewed information summary about the treatment of plasma cell neoplasms (including multiple myeloma).
x